Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Myocardial infarction and nicotine patch: a contributing or causative factor?

Literature DB >> 8131771

Myocardial infarction and nicotine patch: a contributing or causative factor?

A Dacosta¹, J M Guy, B Tardy, R Gonthier, L Denis, M Lamaud, A Cerisier, H Verneyre.

Abstract

A case of angina pectoris revealed by nicotine patch treatment is described in a patient who continued to smoke and subsequently suffered a myocardial infarction. The various side effects of nicotine and its derivatives are recalled. The action of nicotine on coronary vasomotricity and its mediators is discussed.

Entities: Chemical Disease Species

Mesh：

Substances：
Nicotine

Year: 1993 PMID： 8131771 DOI： 10.1093/eurheartj/14.12.1709

Source DB: PubMed Journal: Eur Heart J ISSN： 0195-668X Impact factor: 29.983

Keyword Cloud
Cited

14 in total

1. Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors:
Journal: Heart Date: 1998-12 Impact factor: 5.994

2. Data mining in pharmacovigilance: lessons from phantom ships.

Authors: Manfred Hauben; Lester Reich; Eugène P Van Puijenbroek; Charles M Gerrits; Vaishali K Patadia
Journal: Eur J Clin Pharmacol Date: 2006-08-03 Impact factor: 2.953

Review 3. Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.

Authors: Abhishek Sharma; Saurabh Thakar; Carl J Lavie; Jalaj Garg; Parasuram Krishnamoorthy; Ondrej Sochor; Armin Arbab-Zadeh; Edgar Lichstein
Journal: Curr Cardiol Rep Date: 2015-01 Impact factor: 2.931

Review 4. Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.

Authors: Sonal Singh; Yoon K Loke; John G Spangler; Curt D Furberg
Journal: CMAJ Date: 2011-07-04 Impact factor: 8.262

10. Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case-cross-over study.

Authors: Kyla H Thomas; Neil M Davies; Amy E Taylor; Gemma M J Taylor; David Gunnell; Richard M Martin; Ian Douglas
Journal: Addiction Date: 2020-12-14 Impact factor: 6.526

Myocardial infarction and nicotine patch: a contributing or causative factor?

1. Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

2. Data mining in pharmacovigilance: lessons from phantom ships.

Review 3. Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.

Review 4. Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.

Review 5. Nicotine and Nicotine Replacement Therapy Use During Myocardial Perfusion Imaging.

6. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.

Review 7. The role of pharmacotherapy in assisting smoking cessation.

Review 8. Cardiovascular effects of pharmacologic therapies for smoking cessation.

9. Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death.

10. Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case-cross-over study.